Akcje Organon rosną o 8,4% po doniesieniach o ofercie Sun Pharma za 12 mld $
- PrzezInvesting.com•
Ost. | Max. | Min. | |||||
|---|---|---|---|---|---|---|---|
| 2.359,40 | 2.374,00 | 2.272,00 | +90,05 | +3,97% | 127,14K | ||
| 1.351,45 | 1.358,70 | 1.326,20 | +32,85 | +2,49% | 227K | ||
| 924,40 | 925,80 | 905,60 | +20,80 | +2,30% | 266,01K | ||
| 1.808,60 | 1.814,75 | 1.777,15 | +41,45 | +2,35% | 174,53K | ||
| 1.870,00 | 1.874,50 | 1.860,00 | +11,20 | +0,60% | 77,88K | ||
| 1.450,90 | 1.458,65 | 1.421,00 | -14,30 | -0,98% | 109,94K | ||
| 810,40 | 814,30 | 801,15 | +13,15 | +1,65% | 1,1M | ||
| 2.155,60 | 2.169,75 | 2.121,80 | +21,90 | +1,03% | 114,61K | ||
| 1.322,00 | 1.324,20 | 1.289,40 | +41,25 | +3,22% | 455,32K | ||
| 830,60 | 835,00 | 816,55 | +15,70 | +1,93% | 71,86K | ||
| 1.292,35 | 1.323,00 | 1.283,60 | -39,15 | -2,94% | 627,41K | ||
| 304,20 | 305,35 | 301,50 | +1,20 | +0,40% | 1,75M | ||
| 374,75 | 379,15 | 372,00 | +2,80 | +0,75% | 2,67M | ||
| 3.959,90 | 3.966,00 | 3.910,35 | +62,70 | +1,61% | 156,32K | ||
| 3.261,80 | 3.269,00 | 3.179,05 | +94,50 | +2,98% | 113,7K | ||
| 13.710,95 | 13.797,50 | 13.591,35 | +121,10 | +0,89% | 17,22K | ||
| 1.475,10 | 1.478,00 | 1.438,95 | +27,80 | +1,92% | 124,19K | ||
| 380,30 | 384,30 | 372,05 | +1,85 | +0,49% | 550,31K | ||
| 302,60 | 303,45 | 299,75 | +4,45 | +1,49% | 592,76K | ||
| 1.350,15 | 1.352,10 | 1.331,60 | +20,75 | +1,56% | 501,42K | ||
| 1.066,70 | 1.069,25 | 1.046,95 | +25,80 | +2,48% | 716,73K | ||
| 1.654,70 | 1.700,00 | 1.630,75 | -62,65 | -3,65% | 339,14K | ||
| 2.524,35 | 2.587,80 | 2.501,70 | -63,40 | -2,45% | 496,02K | ||
| 342,55 | 343,70 | 335,15 | +9,35 | +2,81% | 433,05K | ||
| 206,60 | 209,00 | 204,75 | +1,35 | +0,66% | 2,04M | ||
| 1.440,40 | 1.461,50 | 1.426,20 | -21,05 | -1,44% | 38,74K | ||
| 4.502,15 | 4.524,00 | 4.427,75 | +65,25 | +1,47% | 49,93K | ||
| 11.589,90 | 11.640,00 | 11.480,00 | +147,85 | +1,29% | 66,39K | ||
| 1.249,00 | 1.251,70 | 1.229,10 | +19,95 | +1,62% | 33,7K | ||
| 240,25 | 242,50 | 237,15 | +2,35 | +0,99% | 1,67M |
Nie zaplanowano żadnych raportów na temat zysków